Webcast ImageWebcast - Live
WuXi Pharmatech Third Quarter 2014 Earnings Conference Call
11/13/14 at 9:00 p.m. SGT
WuXi Pharmatech Third Quarter 2014 Earnings Conference Call
Thursday, November 13, 2014 9:00 p.m. SGT  through Thursday, November 13, 2014 
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile
WuXi PharmaTech (pronounced woo-shee pharma-tek) is a leading global contract R&D services provider serving the pharmaceutical, biotech, and medical device industries. The company is headquartered in Shanghai and has operations in both China and the United States. We provide a broad and integrated portfolio of laboratory and manufacturing services throughout the R&D process. Our services are designed to help our global partners shorten the time and lower the cost of R&D. The parent company is known as WuXi PharmaTech, and its operating divisions are known as WuXi AppTec (pronounced woo-shee app-tek)... More >>
What's New
download pdf  Investor Fact Sheet
Recent NewsMore >>
DateTitle 
10/30/14WuXi AppTec Launches Representative Office in Israel, Forms Strategic Collaboration with Pontifax
SHANGHAI, Oct. 30, 2014 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced the establishment of a representative office in the Tel Aviv area of Israel.  The new office will promote WuXi's broad platform of integrated R&D services to local customers. It will also collaborate ... 
Printer Friendly Version
10/23/14WuXi Congratulates TaiMed Biologics on Receiving Orphan Drug Designation for Ibalizumab from U.S. FDA
SHANGHAI, Oct. 23, 2014 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China and the United States, today congratulates its partner TaiMed Biologics for receiving the Orphan Drug Designation from U.S. FDA for ibalizumab, a humanized monoclonal antibody for the treatment of HIV/AIDS infection. This is a significant milestone that brings ibalizumab one step closer to patients. "We ... 
Printer Friendly Version
10/22/14Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China
Collaboration to address needs of biopharmaceutical companies conducting clinical R&D in China CAMBRIDGE, Mass. and SHANGHAI, Oct. 22, 2014 /PRNewswire/--  Foundation Medicine, Inc. (NASDAQ:FMI) and WuXi PharmaTech (Cayman) Inc. (NYSE:WX) today announced a collaboration to offer Foundation Medicine's comprehensive genomic profiling to biopharmaceutical companies conducting clinical trials in China. Under the terms of the collaboration, Foundation Medicine will license and ... 
Printer Friendly Version
10/21/14WuXi PharmaTech Schedules Third-Quarter 2014 Earnings Release
SHANGHAI, Oct. 21, 2014 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology and medical device industries, with operations in China and the United States, today announced that it will release financial results for the third quarter of 2014 after the New York Stock Exchange closes on Wednesday, November 12, 2014 (which will be Thursday morning, November 13, 2014 Shanghai time).... 
Printer Friendly Version
Upcoming EventsMore >>
DateTitleAdd to
Calendar Help
Remind
Me
Prior to
Event
11/11/14 9:00 a.m. HKT
WuXi PharmaTech (Cayman) Inc. 2014 Annual Shareholder Meeting
Add WuXi PharmaTech (Cayman) Inc. 2014 Annual Shareholder Meeting  to Calendar days
11/13/14 9:00 p.m.
through
11/13/14 10:00 p.m. SGT
WuXi Pharmatech Third Quarter 2014 Earnings Conference Call
Add WuXi Pharmatech Third Quarter 2014 Earnings Conference Call to Calendar days
Enter your e-mail address 
Stock QuoteMore >>
WX (Common Stock)
ExchangeNYSE (US Dollar)
Price$37.70
Change (%) Stock is Down 0.05 (0.13%)
Volume322,666
Data as of 10/31/14 4:04 p.m. ET
Minimum 20 minute delay
Refresh quote
CalendarMore >>
November 2014?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
Presentations
52 Week High
Today
SunMonTueWedThuFriSat
-6-5-4-3-2-11
2345678
9101112131415
16171819202122
23242526272829
30515253545556
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever WuXi PharmaTech (Cayman) Inc. posts new information to the site. Just enter your e-mail address and click Submit.
 

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.